Jounce Therapeutics, Inc.

Jounce Therapeutics, Inc.verified

JNCE

Price:

$1.88

Market Cap:

$98.95M

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics...[Read more]

Industry

Biotechnology

IPO Date

2017-01-26

Stock Exchange

NASDAQ

Ticker

JNCE

The Dividend Yield as of October 2024 (TTM) for Jounce Therapeutics, Inc. (JNCE) is 0%

According to Jounce Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Jounce Therapeutics, Inc. (JNCE) Historical Dividend Yield (quarterly & annually)

How has JNCE Dividend Yield performed in the past?

The mean historical Dividend Yield of Jounce Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), JNCE's Dividend Yield was at its highest in in the December 2015 quarter at 0%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Jounce Therapeutics, Inc. (JNCE) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Jounce Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%

Jounce Therapeutics, Inc. (JNCE) Average Dividend Yield

How has JNCE Dividend Yield performed in the past?

The current Dividend Yield of Jounce Therapeutics, Inc. (JNCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Jounce Therapeutics, Inc. (JNCE) Dividend Yield vs. Peers

How is JNCE’s Dividend Yield compared to its peers?

Jounce Therapeutics, Inc.’s Dividend Yield is less than Assembly Biosciences, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Achilles Therapeutics plc (0%), less than Instil Bio, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than NextCure, Inc. (0%), less than Nuvation Bio Inc. (0%),

Build a custom stock screener for Jounce Therapeutics, Inc. (JNCE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jounce Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Jounce Therapeutics, Inc. (JNCE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Jounce Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Jounce Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Jounce Therapeutics, Inc. (JNCE)?

What is the highest Dividend Yield for Jounce Therapeutics, Inc. (JNCE)?

What is the 3-year average Dividend Yield for Jounce Therapeutics, Inc. (JNCE)?

What is the 5-year average Dividend Yield for Jounce Therapeutics, Inc. (JNCE)?

How does the current Dividend Yield for Jounce Therapeutics, Inc. (JNCE) compare to its historical average?